Algard Liquid (Sodium Alginate)

Adult dose

For hemostasis and improvement of subjective symptoms of gastric and duodenal ulcers and erosive gastritis and improvement of subjective symptoms of gastroesophageal reflux disease: typically, sodium alginate is taken orally at 1-3g (approximately 20-60mL) 3-4 times a day on an empty stomach. If oral administration is not possible, it is administered via nasal tube (sonde). For hemostasis during gastric biopsy bleeding: typically, this medication is administered endoscopically at 0.5-1.5g (approximately 10-30mL) and 1.5g (approximately 30mL) is taken orally.

This medication reacts with gastric acid in the stomach to form a gel. If this process does not occur properly, the effectiveness of the medication may be reduced. Therefore, if there is insufficient gastric acid, it may be difficult to achieve the expected effects. Gastrointestinal symptoms such as diarrhea or constipation may occur during administration, so if any of these symptoms arise, discontinue use immediately and consult a doctor or dentist. It is advisable to carry the attached document containing information about this medication during the consultation.

Mild side effects

Symptoms such as diarrhea and constipation may occasionally appear.

This medication should be stored in a sealed container to avoid exposure to air or moisture and is safely stored at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent deterioration.

Appearance

A viscous green liquid contained in an aluminum foil pouch

Package unit

40 packets/box [20mL/packet X 40]